Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Advanced Solid Tumors × netrin-1 inhibitor NP137 × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Advanced Solid Tumors 1

Interventions

Paclitaxel 2 Injections 2 tislelizumab 1 sotorasib 1 osimertinib 1 netrin-1 inhibitor NP137 1 lazertinib 1 fluzoparib 1 camrelizumab 1 Panitumumab 1 PM 01183 1 Nivolumab 1 Ipilimumab 1 HMPL-013 1 Erlotinib Hydrochloride 1 Dexamethasone 1 Calcium Dobesilate 1 Bortezomib 1 Bevacizumab 1 3-(8-amino-1-(2-phenylquinolin-7-yl)imidazo(1,5-a)pyrazin-3-yl)-1-methylcyclobutanol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05605496 2026-02-10

IMMUNONET

Centre Leon Berard

Phase 2 Active not recruiting

Other solid neoplasm

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡